0
World
Samsung Biologics posts strong Q1 profit growth
April 22, 2026
Scroll
Posted 2 hours ago by
Samsung Biologics, the biotech arm of Samsung Group, reported strong first-quarter results, with net profit rising 41.6 year-on-year, driven by full-capacity operations at its key production facilities, AzerNEWS reports, citing Yonhap agency.
AzerNews
Coverage and analysis from Azerbaijan. All insights are generated by our AI narrative analysis engine.
Azerbaijan
Bias: Unknown
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.